Scarica l'app Stockscreener
19.28
2.01%
0.38
Dopo l'orario di chiusura:
18.90
-0.38
-1.97%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KVUE Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$18.90
Aprire:
$18.88
Volume 24 ore:
17.05M
Relative Volume:
0.87
Capitalizzazione di mercato:
$37.02B
Reddito:
$15.29B
Utile/perdita netta:
$1.62B
Rapporto P/E:
22.86
EPS:
0.8433
Flusso di cassa netto:
$1.82B
1 W Prestazione:
+1.58%
1M Prestazione:
+2.55%
6M Prestazione:
+8.31%
1 anno Prestazione:
-14.31%
Intervallo 1D:
$18.83
$19.28
Intervallo di 1 settimana:
$18.77
$19.28
Portata 52W:
$14.02
$22.87
Kenvue Inc Stock (KVUE) Company Profile
Nome
Kenvue Inc
Settore
Industria
Telefono
908-874-1200
Indirizzo
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, KMB
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
19.28 | 36.29B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
147.41 | 342.23B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
60.94 | 129.64B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
90.75 | 72.08B | 20.80B | 2.22B | 3.77B | 2.5772 |
KMB
Kimberly Clark Corp
|
109.70 | 35.62B | 16.56B | 1.75B | 1.84B | 6.36 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-30 | Downgrade | Jefferies | Buy → Hold |
| 2025-10-29 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2025-09-26 | Aggiornamento | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | Iniziato | Redburn Atlantic | Neutral |
| 2025-03-24 | Iniziato | Evercore ISI | In-line |
| 2025-01-06 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-09-24 | Iniziato | Jefferies | Buy |
| 2024-09-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | Ripresa | Citigroup | Neutral |
| 2024-04-11 | Iniziato | Bernstein | Underperform |
| 2024-04-03 | Iniziato | William Blair | Mkt Perform |
| 2024-03-01 | Ripresa | Goldman | Neutral |
| 2023-11-17 | Iniziato | Piper Sandler | Neutral |
| 2023-09-11 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2023-09-07 | Iniziato | Canaccord Genuity | Buy |
| 2023-09-06 | Iniziato | Argus | Hold |
| 2023-08-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-07-25 | Iniziato | Edward Jones | Buy |
| 2023-06-01 | Iniziato | HSBC Securities | Hold |
| 2023-05-30 | Iniziato | BofA Securities | Buy |
| 2023-05-30 | Iniziato | Citigroup | Neutral |
| 2023-05-30 | Iniziato | Deutsche Bank | Hold |
| 2023-05-30 | Iniziato | Exane BNP Paribas | Neutral |
| 2023-05-30 | Iniziato | Goldman | Neutral |
| 2023-05-30 | Iniziato | JP Morgan | Overweight |
| 2023-05-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-05-30 | Iniziato | UBS | Neutral |
Mostra tutto
Kenvue Inc Borsa (KVUE) Ultime notizie
US FDA approves over-the-counter Tylenol combination pill for pain relief - Reuters
Kenvue Inc. stock rises Friday, outperforms market - MarketWatch
Kenvue Inc (KVUE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kenvue Inc (KVUE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kenvue Says FDA Has Granted Tylenol Three-Year Exclusivity For New OTC Formulation - TradingView
FDA approves Tylenol® with Naproxen, the first and only over-the-counter fixed-dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) - Kenvue
Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)? - simplywall.st
Kenvue Inc (KVUE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It - The Motley Fool
Jim Cramer Says Kimberly-Clark’s Acquisition of Kenvue Creates a High-Margin Powerhouse - Yahoo Finance
Mizuho Markets Americas LLC Trims Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Listerine Cool Mint by Kenvuemouthwash classic boosts oral care sales - Ad-hoc-news.de
Capula Management Ltd Grows Position in Kenvue Inc. $KVUE - MarketBeat
Caxton Associates LLP Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Thursday, still outperforms market - MarketWatch
Kenvue to announce Q2 2026 results on August 6, 2026 - scanx.trade
Press Release: Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - 富途牛牛
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - The Joplin Globe
Levin Capital Strategies L.P. Raises Stake in Kenvue Inc. $KVUE - MarketBeat
Technical Reactions to KVUE Trends in Macro Strategies - Stock Traders Daily
Kenvue Inc. (NYSE:KVUE) Given Average Rating of "Hold" by Analysts - MarketBeat
KVUE|Kenvue Inc|Price:18.990|Chg%:+0.090 - TradingKey
Kenvue broadens China focus on minor ailment management - China Daily Global Edition
What to expect from Kenvue’s Q2 2026 earnings report - MSN
KBC Group NV Increases Holdings in Kenvue Inc. $KVUE - MarketBeat
SEB Asset Management AB Purchases New Position in Kenvue Inc. $KVUE - MarketBeat
Dimensional Fund Advisors LP Has $383.94 Million Position in Kenvue Inc. $KVUE - MarketBeat
The Listerine Cool Mint MouthwashKenvue bets on bold flavor and plaque control - Ad-hoc-news.de
Kenvue stock steadies as consumer health margins lift earnings outlook - Ad-hoc-news.de
Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating - marketscreener.com
What to Expect From Kenvue’s Q2 2026 Earnings Report - Barchart.com
Kenvue Inc. $KVUE Shares Sold by Kapitalo Investimentos Ltda - MarketBeat
Swiss National Bank Has $96.94 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health spin-off builds earnings record - Ad-hoc-news.de
Kenvue Inc. (KVUE) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Kenvue Inc. $KVUE Stake Lifted by Hsbc Holdings PLC - MarketBeat
California Public Employees Retirement System Decreases Stake in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock holds steady as the latest report frames 2026 margins - Ad-hoc-news.de
Bank of New York Mellon Corp Sells 223,497 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health margins hold after spin-off - ad-hoc-news.de
Listerine Cool Mint by Kenvue Inc.mouthwash classic fuels recurring sales - ad-hoc-news.de
How Affirmed Talc Successor Liability At Kenvue (KVUE) Has Changed Its Investment Story - simplywall.st
Illinois Municipal Retirement Fund Buys 72,348 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health margins stay in focus - ad-hoc-news.de
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
KVUE Maintained by UBS -- Price Target Raised to $20.00 - GuruFocus
Diversify Wealth Management LLC Buys New Stake in Kenvue Inc. $KVUE - MarketBeat
Blackhawk Capital Partners LLC Invests $1.66 Million in Kenvue Inc. $KVUE - MarketBeat
Daily Brief Consumer: Colowide Co Ltd, Seven & I Holdings, Alibaba, New Hope Dairy Co Ltd, Global Education Communities C, Kenvue , Netflix Inc, Shadowfax Technologies, Suminoe Textile, Tailored Brands and more - Smartkarma
Neutrogena® announces 'Break the Rules' to break beauty's rules with scienceA new view of care - Kenvue
Kenvue stock holds steady as investors wait for the next catalyst - ad-hoc-news.de
Kenvue Inc Azioni (KVUE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):